Showing results (331-340 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|July 2, 2022
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data AnalysisChristof Scheid, Robert Kudernatsch, Marie Eckart, et al.
Drugs - Real World Outcomes|December 28, 2020
Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with PolypharmacyAkio Negishi, Shinji Oshima, Norimitsu Horii, et al.
Drugs - Real World Outcomes|May 23, 2022
Itraconazole Contaminated with Rilmazafone in Japan: A Retrospective Analysis Using the Japanese Adverse Drug Event Report DatabaseMasami Tsuchiya, Taku Obara, Nariyasu Mano
Drugs - Real World Outcomes|August 29, 2019
Development and Application of a Measurement Framework to Evaluate Safe, Effective and Efficient Medication Use Among Older AdultsAmi Vyas, Emily Patry, Norma Owens, et al.
Drugs - Real World Outcomes|January 31, 2021
Patient Characteristics and Utilization Patterns of Short-Acting Recombinant Granulocyte Colony-Stimulating Factor (G-CSF) Biosimilars Compared to Their Reference ProductAaron B Mendelsohn, James Marshall, Cara L McDermott, et al.
Drugs - Real World Outcomes|February 11, 2021
Using Medicare Data to Assess the Proarrhythmic Risk of Non-Cardiac Treatment Drugs that Prolong the QT Interval in Older Adults: An Observational Cohort StudyKin Wah Fung, Fitsum Baye, Joan Kapusnik-Uner, et al.
Drugs - Real World Outcomes|December 10, 2016
Pharmacist's Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient AdmissionFaiza Rhalimi, Mounir Rhalimi, Alain Rauss
Drugs - Real World Outcomes|February 28, 2019
Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center ExperienceYuko Matsui, Atsushi Suzuki, Tsuyoshi Shiga, et al.
Drugs - Real World Outcomes|August 4, 2019
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional CommunicationJavier Cid Ruzafa, Sinna Pilgaard Ulrichsen, Dimitri Bennett, et al.
Drugs - Real World Outcomes|July 31, 2019
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not WorkJean-Pierre Boissel, Frédéric Cogny, Nicholas Marko, et al.
Pageof 55